Hematology TimesPharma is gaming the system for orphan drugs, investigation suggestsJanuary 19, 2017PharmacyRelated Issues
Hematology TimesFDA releases draft guidances on biosimilars, medical communicationsJanuary 19, 2017PharmacyRelated Issues
Hematology TimesFDA issues CRL for IV formulation of antiemetic agentJanuary 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Hematology TimesVenetoclax approved to treat CLL in AustraliaJanuary 12, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCombo granted orphan designation for CLLJanuary 10, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCompany withdraws MAA for biosimilar pegfilgrastimDecember 29, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology TimesBendamustine approved for new indication in JapanDecember 23, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesDrug granted fast track designation for PNHDecember 22, 2016AnemiaThrombosisPharmacyBleeding Disorders
Hematology TimesJCAR017 gets PRIME access, breakthrough designationDecember 21, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesCHMP recommends authorization of rituximab biosimilarDecember 18, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
